OTC Markets OTCPK - Delayed Quote • USD Perimeter Medical Imaging AI, Inc. (PYNKF) Follow Compare 0.3300 0.0000 (0.00%) At close: January 22 at 7:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Bullish Perimeter Medical Imaging AI Insiders Loaded Up On US$3.51m Of Stock Multiple insiders secured a larger position in Perimeter Medical Imaging AI, Inc. ( CVE:PINK ) shares over the last 12... Perimeter Provides Update on Canada Postal Strike and Mailing of the Company's 2024 Annual General Meeting Materials Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, wishes to notify shareholders that in case of disruption due to the ongoing Canada Post strike, the Company's meeting materials (the "Meeting Materials") for the Company's upcoming annual general meeting to be held on December 12, 2024 at 1:00 p.m. (Toronto Time) (the "Meeting"), may be viewed on the Company's SEDAR+ profile at www.sedarplus.ca and are also Perimeter B-Series OCT with ImgAssist AI 2.0 Demonstrates Super-Superiority Compared to Standard-of-Care in Pivotal Clinical Trial Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced positive topline results from the pivotal study designed to support its planned Premarket Approval Application ("PMA") submission to the U.S. Food and Drug Administration ("FDA") for approval to market the Company's next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence ("AI") technology with optical Perimeter Medical Imaging to Announce Topline Results from Pivotal Clinical Trial Evaluating B-Series OCT with ImgAssist AI in Breast-Conserving Surgeries on November 20th; Conference Call to Follow Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced that it will report topline results from the pivotal study evaluating the use of its next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence ("AI") technology with optical coherence tomography ("OCT"), during breast-conserving surgeries after market close on Wednesday, November 20, 2024. Following the annou Perimeter Medical Imaging AI Reports Third Quarter 2024 Financial Results and Provides Corporate Update Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its third quarter ended September 30, 2024 and provided a corporate update. Perimeter Medical Imaging AI to Report Third Quarter 2024 Financial Results and Host Conference Call on November 14, 2024 Perimeter Medical Imaging AI, Inc. (TSXV: PINK)(OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its third quarter 2024 financial and operating results after market close on Thursday, November 14, 2024. Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update. Perimeter Medical Imaging AI Announces Additional Closing of Non-Brokered Private Placement Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the second and final closing (the "Second Closing") of its non-brokered private placement of common shares in the capital of the Company ("Common Shares") announced on September 10, 2024 (the "Offering"). Perimeter Announces Completion of Patient Enrollment in Pivotal Clinical Trial Evaluating OCT B-Series with ImgAssist AI in Breast-Conserving Surgeries Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced the completion of patient enrollment in a pivotal study evaluating the use of its next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence ("AI") technology with optical coherence tomography ("OCT"), during breast-conserving surgeries ("BCS"). Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the closing of its non-brokered private placement of common shares in the capital of the Company ("Common Shares") announced on September 10, 2024 (the "Offering"). Perimeter Medical Imaging AI Announces Non-Brokered Private Placement Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that it is undertaking a non-brokered private placement of up to 32,175,032 common shares in the capital of the Company ("Common Shares") at a price of $0.42 per Common Share, for aggregate gross proceeds of up to approximately $13.5 million (the "Offering"). All dollar figures are quoted in Canadian dollars. Perimeter Medical Imaging AI Second Quarter 2024 Earnings: Beats Expectations Perimeter Medical Imaging AI ( CVE:PINK ) Second Quarter 2024 Results Key Financial Results Net loss: US$3.18m (loss... Perimeter Medical Imaging AI Reports Second Quarter 2024 Financial Results and Provides Corporate Update Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its second quarter ended June 30, 2024 and provided a corporate update. Ingredion sees falling income, continues to focus on texture The Illinois ingredients giant saw a 9% year-over-year decline in the second quarter. Perimeter Medical Imaging AI to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024 Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its second quarter 2024 financial and operating results after market close on Wednesday, August 14, 2024. Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update. Perimeter Medical Imaging AI to Host Investor Webcast on June 25 Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company, today announced that it will host a webcast investor presentation on Tuesday, June 25, 2024 at 2:00 PM ET. Perimeter Medical Imaging AI Reports Report First Quarter 2024 Financial Results and Provides Corporate Update Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its first quarter ended March 31, 2024 and provided a corporate update. Perimeter Medical Imaging AI to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Tuesday, May 14, 2024. Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update. Ingredients in Focus: Ingredion’s PureCircle launches a ‘first of its kind’ drop-in stevia sweetener The solution is considered a natural origin sweetener that mimics sugar without additives and can be used in beverages, syrups and sauces, according to the company. Perimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applications Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced a newly published webinar, "Trends in Artificial Intelligence (AI) and Innovators in Healthcare" featuring a fireside chat with Anantha Kancherla, former head of Meta's AI platform, and current member of Perimeter's Board, alongside Perimeter's CEO, Adrian Mendes. Perimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updates Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it will participate in the upcoming American Society of Breast Surgeons (ASBrS), featuring interactive demos of the S-Series OCT device at the Company's booth. The Company also announced the grant of certain stock options and the engagement of Velocity Trade Capital Ltd. ("Velocity Trade") for market liquidity services. Performance Overview Trailing total returns as of 1/23/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return PYNKF S&P/TSX Composite index YTD +26.92% +3.30% 1-Year -60.24% +21.55% 3-Year -88.26% +23.34%